PMEF
KURA icon

Point72 Middle East FZE’s Kura Oncology KURA Stock Holding History

Point72 Middle East FZE’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,366
Closed -$293K – 732
2023
Q4 		$293K Buy
+20,366
New +$200K 0.01% 963
2023
Q2 		– Sell
-522
Closed -$6.38K – 1829
2023
Q1 		$6.38K Sell
522
-8,721
-94% -$109K ﹤0.01% 1508
2022
Q4 		$115K Buy
+9,243
New +$134K 0.01% 1227

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Point72 Middle East FZE's KURA Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Kura Oncology (KURA) in Q1 2024, closing a stake of 20,366 shares — an estimated $293K sold.

Point72 Middle East FZE first reported a position in KURA in Q4 2022 and held it in 3 quarters. The position peaked at $293K in Q4 2023. 165 funds tracked by Wall St. Rank hold KURA as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Kura Oncology position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 20,366 Kura Oncology shares in Q1 2024, an estimated $293K.
  • Point72 Middle East FZE first reported a position in Kura Oncology in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Kura Oncology position peaked at $293K in Q4 2023.
  • 165 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.